Proteolytic Processing of Stat6 Signaling in Mast Cells as a Negative Regulatory Mechanism
The Journal of Experimental Medicine 196(1): 27-38
Article 2002 English
Authors
KS
Kotaro Suzuki
HN
Hiroshi Nakajima
SK
Shin‐ichiro Kagami
Abstract
1 min read
Accumulating evidence has shown the importance of Stat6-mediated signaling in allergic diseases. In this study, we show a novel regulatory mechanism of Stat6-mediated signaling in mast cells. When Stat6 is activated by interleukin (IL)-4 and translocated to the nucleus, Stat6 is cleaved by a nucleus-associated protease in mast cells. The cleaved 65-kD Stat6 lacks the COOH-terminal transactivation domain and functions as a dominant-negative molecule to Stat6-mediated transcription. The retrovirus-mediated expression of cleavage-resistant Stat6 mutants prolongs the nuclear accumulation of Stat6 upon IL-4 stimulation and enhances IL-4–induced gene expression and growth inhibition in mast cells. These results indicate that the proteolytic processing of Stat6 functions as a lineage-specific negative regulator of Stat6-dependent signaling in mast cells, and thus suggest that it may account for the limited role of Stat6 in IL-4 signaling in mast cells.
Katsuyuki Tomita, Gaetano Caramori, Kazuhiro Ito, Hiroyuki Sano, Sam Lim, Timothy Oates, Borja G. Cosío, Kian Fan Chung, Yuji Tohda, Peter J Barnes, Ian M. Adcock
Roser Vento‐Tormo, Carlos Company, Javier Rodríguez‐Ubreva, Lorenzo de la Rica, José Urquiza, Biola M. Javierre, Radhakrishnan Sabarinathan, Ana Luque, Manel Esteller, Josep M. Aran, Damiana Álvarez‐Errico, Esteban Ballestar
Discussion(0)
No comments yet. Be the first to comment.